8x8 Inc vs McKesson Corporation — how do they compare? 8x8 Inc trades at $2.02 (market cap $279.31M), while McKesson Corporation trades at $836.1 (market cap $93.23B). The key difference: McKesson Corporation is far larger — about 333.8× 8x8 Inc's market cap, and McKesson Corporation pays a 0.41% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals.
| EGHT | MCK | |
|---|---|---|
Market Cap | $279.31M | $93.23B |
Sector | Technology | Health |
52-Week High | $2.76 | $995.69 |
52-Week Low | $1.59 | $659.01 |
Enterprise Value | $556.99M | $97.87B |
Dividend Yield | — | 0.41% |
Signals from Pluang's Aura AI — not financial advice
EGHT (8x8, Inc.) trades at $2.035, down 6.22% on the day. The stock shows a bullish technical signal from moving averages, though oscillators are neutral. Fundamentally, the company reported a net loss of $27.21M for 2025 but has beaten EPS estimates for three consecutive quarters. Recent news highlights product innovation with AI Routing and Pulse solutions, and the company was named a 2026 MetriStar Top Provider for CPaaS. Revenue grew to $715.07M in 2025, with a forecasted return to profitability in 2026.
The outlook hinges on the company's transition to profitability, projected for 2026 with a net profit of $2M. Investment opportunities include continued revenue growth, successful execution of new AI-driven products, and cost discipline. Key risks are the high P/E ratio of 197, significant long-term debt of $338.37M, and the challenge of sustaining recent earnings beats. Analyst sentiment is mixed but leans positive, with 39% Buy ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →